RICHMOND HILL, NY, June 26, 2023 (Globe Newswire) — AI-based health screening company iHealthScreen recently announced price increases. $150,000 Investing in StartEngine. The company has so far $3 million or more Combined seed and NIH funding.
iHealthScreen offers a unique opportunity to leverage AI-driven health screening software developed by medical professionals who are emerging leaders in the field. A multi-billion dollar market. This integrated retinal imaging-based system is unprecedented in the surgical robotics industry.
iHealthScreen is the first company in the world To obtain CE certification and Australian and UAE health approvals for age-related macular degeneration (“AMD”), diabetic retinopathy (“DR”) and glaucoma screening. Moreover, hospitals do not have to use the company’s surgical robots. The system can be incorporated into community-level primary care provider facilities.
U.S. testing is notoriously expensive for those who need it most, and primary care providers lack the resources to do more than basic testing. This can prevent patients from getting necessary tests, which can lead to serious health consequences.
iHealthScreen capitalizes on this problem by developing a quick, easy, accessible, low-cost solution for eye disease screening.
Investment highlights:
- Raised $750,000 in seed funding.
- Obtained $2.7 million in funding from NIH.
- We are working to secure additional research grants.
- 1 U.S. Patent (first patent in late AMD prediction).
- One patent is pending and four provisional patent applications have been filed.
- An existing customer already exists.
For those interested in funding iHealthScreen and its crowdfunding, please visit the company’s funding page on StartEngine. learn more.
About iHealthScreen
iHealthScreen’s integrated retinal imaging-based system makes the company one of the first companies in the world to receive CE certification, AMD, DR and Australian and UAE health approvals for glaucoma screening. The company has gained international attention with contracts in the US, EU, Bangladesh and UAE, and is working with Global Victoria in Australia.
Company contact:
Alauddin Bhuiyan
Founder and CEO
bhuiyan@ihealthscreen.org
728-926-9000
New York, NY 11418
Wire service contact:
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 office
Editor@InvestorBrandNetwork.com
